Testing painkiller injection for heart attack patients
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if injecting a painkiller near neck nerves can reduce heart damage after a heart attack. It is for patients with a specific type of heart attack who are scheduled for a procedure to open blocked arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a heart attack with specific changes on your ECG (ST elevation).
- You are scheduled for a procedure to open blocked heart arteries (PCI).
- You have chest pain that started within the last 24 hours.
- You are not taking blood thinners or have bleeding problems.
- You are not allergic to opioids and have no history of opioid addiction.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests selatogrel to see if it can better prevent harmful heart and blood-clot outcomes after a recent heart attack. You may be considered if you had a heart attack in the past 4 weeks and have higher-risk heart artery disease.
This trial tests whether giving specially prepared stem cells from your own blood can help your heart recover after a heart attack. You must have had a successful angioplasty or stenting within the last 4 weeks.
This study tests if a painkiller (morphine) injected near certain neck nerves can reduce damage to the heart muscle during a heart attack procedure. It is for people having a specific type of heart attack and who will get a stent to open the blocked artery.
This trial tests whether a half-dose medicine called r-SAK given before a primary PCI heart stent procedure improves outcomes and safety in people with a specific type of heart attack. It may help the heart recover better, but it also checks the risk of side effects like bleeding.
This study tests whether an ultrasound-guided numbing injection in the belly wall can reduce pain during heart procedures like angioplasty or stent placement. It is for people having planned (non-emergency) heart catheterization.
This trial tests if a fast-acting inhaled painkiller called methoxyflurane can safely reduce severe chest pain in people having a type of heart attack (STEMI) before they reach the hospital. It's for those who haven't already gotten pain medicine for this episode.
Hear when a new Acute Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.